<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-6XAQHT7K</identifier><date>2023</date><creator>Preložnik Zupan, Irena</creator><creator>Rener, Karla</creator><relation>documents/doc/6/URN_NBN_SI_doc-6XAQHT7K_001.pdf</relation><relation>documents/doc/6/URN_NBN_SI_doc-6XAQHT7K_001.txt</relation><format format_type="issue">2</format><format format_type="volume">74</format><format format_type="type">article</format><format format_type="extent">str. 125-130</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID">189907971</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-6XAQHT7K</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">faktorji strjevanja krvi</subject><subject language_type_id="slv">genska terapija</subject><subject language_type_id="slv">hemofilija A in B</subject><subject language_type_id="slv">nefaktorsko zdravljenje</subject><title>Novosti v zdravljenju hemofilije</title><title>New developments in haemophilia treatment</title></Record>